VanEck Biotech ETF
BBH
118 hedge funds and large institutions have $163M invested in VanEck Biotech ETF in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 7 closing their positions.
114% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 7
35% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 26
6% more funds holding
Funds holding: 111 → 118 (+7)
3% more capital invested
Capital invested by funds: $158M → $163M (+$4.78M)
0.56% more ownership
Funds ownership: 27.47% → 28.03% (+0.56%)
25% less call options, than puts
Call options by funds: $1.36M | Put options by funds: $1.82M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
+$2.34M |
| 2 |
Goldman Sachs
New York
|
+$1.45M |
| 3 |
Morgan Stanley
New York
|
+$1.45M |
| 4 |
KWM
Kingsview Wealth Management
Grants Pass,
Oregon
|
+$1.04M |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$897K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.58M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.35M |
| 3 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$1.26M |
| 4 |
PP
Prudential plc
London, England,
United Kingdom
|
-$1.01M |
| 5 |
BRC
BHF RG Capital
Scottsdale,
Arizona
|
-$720K |
BBH Hedge Fund Activity: Q3 2021 in Review
118 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2021, worth a combined $163M — up 3% from $158M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new BBH positions and 7 closed out — a net gain of 8 holders — while 35 added to existing stakes and 26 trimmed.
The largest buyer was LPL Financial, adding an estimated $2.34M. The largest seller was Susquehanna International Group, cutting an estimated $2.58M.
- 118 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2021, up from 111 in Q2 2021.
- Funds reported $163M of VanEck Biotech ETF stock for Q3 2021, up 3% quarter-over-quarter.
- 15 funds opened new VanEck Biotech ETF positions in Q3 2021 and 7 closed out, a net change of +8 holders.
- The largest VanEck Biotech ETF buyer in Q3 2021 was LPL Financial, an estimated $2.34M added.
- The largest VanEck Biotech ETF seller in Q3 2021 was Susquehanna International Group, an estimated $2.58M sold.
Based on aggregated 13F filings for Q3 2021.